Recent posts

WRIB 2016: Diversity of Platforms and Approaches Needed for Bioanalysts

By May 16, 2016

Held April 18–22 in Lake Buena Vista, Florida, WRIB 2016 was well attended this year, with about 700 attendees. This 10th Workshop on Recent Issues in Bioanalysis, where regulators and professionals representing pharma/biopharma, biotech, CRO… Read more >

Categories: Pharmaceutical
Tags: ,

Simon Fraser University Opens Suite of Mass Spectrometers for Natural Products Discovery Research

By May 9, 2016

As a graduate student at the University of British Columbia, Dr. Roger Linington discovered his future life’s work serendipitously. While studying sponges, it became clear to him that one of the challenges in studying macroorganisms… Read more >

Categories: Pharmaceutical
Tags: , , ,

Out with the old, in with the new…

By May 3, 2016

We’re all familiar with the adage, “Out with the old, in with the new,” but we probably tend to think of it as it applies to clothes for donation or past relationships, and maybe not… Read more >

Categories: Pharmaceutical
Tags: , , ,

It’s all about Good Science

By April 20, 2016

Participating in the 16th annual International Conference on the Science of Botanicals (ICSB), it became clear that academic research institutions, regulatory agencies, and dietary supplement/herbal medicine manufacturers want the same thing – to keep consumers… Read more >

Categories: Pharmaceutical
Tags:

Tof-HRMS: Rescuing Low-Exposure Bioanalysis Applications from Chemical Noise

By April 18, 2016

The drug development process requires pharmacokinetic (PK) analysis to be performed as part of safety and efficacy studies in both preclinical species and human subjects. For high-sensitivity bioanalysis, liquid chromatography (LC) coupled to a triple… Read more >

Categories: Chemical, General, Pharmaceutical, Technologies
Tags: , , , , , , , , , , , ,

Mass detection and mAb QC: How a cost-effective and robust peptide mapping method confirms CDR peptides – and can be validated

By March 15, 2016

The quality issues of biopharmaceutical therapeutics are definitely different from chemical drugs because of the increased complexity of manufacturing processes and complexity of the biologic molecules themselves. There is an increasing need for detailed product… Read more >

Categories: Pharmaceutical, Technologies
Tags: , , , , ,

A View of the Biopharmaceutical Industry in Asia — an Interview with Ken Fountain

By March 14, 2016

Ken Fountain, Director of Biopharmaceutical Business Development at Waters, recently returned from an insightful trip to Asia where he visited Waters customers in South Korea and attended the China Biopharma Executive Summit in Shanghai, in… Read more >

Categories: Pharmaceutical
Tags: , , ,

Metabolic Blurred Lines: Is Biotransformation the next Met ID?

By March 11, 2016

  You are the hunter in a landscape of scientific gatherers, the stealthy SEAL of DMPK, the nimble ninja of ADME. You are a Metabolite ID scientist. Traditionally, Met ID labs have been a fixture… Read more >

Categories: Pharmaceutical
Tags: , , ,

Separations Science Guiding Disease Research at Colorado State University

By March 11, 2016

As infectious diseases go, tuberculosis (TB) is clearly one of the worst. Easily spread through the air by those with an active infection, it is a scourge that is decimating developing countries. The World Health… Read more >

Categories: Customer Stories, Pharmaceutical, Technologies
Tags: , , , ,

Three Reasons for Biopharmaceutical Labs to Add Mass Detection to Routine Analyses

By March 9, 2016

As regulators focus in on the critical quality attributes of biotherapeutics, what can biopharmaceutical labs in late development or QC do to increase confidence in their bioseparations – other than to run more assays?

Categories: Pharmaceutical, Technologies
Tags: , , , , , , , , , , , , , , , , , , , ,